CD34 and triple-A syndrome: CD34+ cell‐specific knockout of PDGFRa exacerbated AAA development but did not elevate animal mortality, as evidenced by the increased maximum diameters of aortas in the Pdgfra−/− group compared with controls, and a comparable survival rate was observed between the two groups (Figure6A,B).